查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2022-2029 年 mRNA 合成原材料的全球市场规模研究和预测，按产品、应用、最终用户、地区分析
市场调查报告书
商品编码
1258080

2022-2029 年 mRNA 合成原材料的全球市场规模研究和预测，按产品、应用、最终用户、地区分析

Global mRNA Synthesis Raw Material Market Size study & Forecast, by Product by Application, by End-user and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

2021 年 mRNA 合成原材料的全球市场价值为 27.46 亿美元，预计在 2022-2029 年的预测期内将以 2.1% 的复合年增长率增长。

mRNA 是使用由 DNA 核甘酸序列组成的模板在细胞核中通过转录过程产生的。 mRNA的适应性和灵活性使其成为开发针对各种慢性病和传染病的治疗性和预防性疫苗的绝佳平台。 癌症和慢性病发病率的增加增加了对基因治疗的需求。

由于对基因治疗的需求不断增长以及慢性病和传染病的增加，预计未来几年 mRNA 合成和製造服务市场将显着增长。 许多市场进入者和研究机构正在获得资金来开发新的 mRNA 疗法。 例如，2022年10月，加拿大政府向哥伦比亚大学提供了1110万美元，用于进一步开发其mRNA疫苗。 在当前的 Covid-2019 大流行期间，许多公司选择了 mRNA 疫苗技术来对抗冠状病毒。 同样，2022 年 12 月，ExPLoRNA Therapeutics 从比尔和梅琳达盖茨基金会获得了 813,578 美元的资金，用于进一步开发其 mRNA 技术。 预计多个市场参与者的新参与将进一步推动市场。 由于缺乏灵活、耐用且价格合理的製造程序，阻碍了 mRNA 合成原材料的开发。 原材料的高成本是进步的主要障碍。

全球 mRNA 合成原料市场研究考虑的主要区域包括亚太地区、北美、欧洲、拉丁美洲和拉丁美洲其他地区。 用于mRNA合成的原材料市场主要由北美主导。 由于辉瑞和摩德纳等知名公司拥有大型 mRNA 疫苗生产设施，预计美国仍将保持行业领先地位。 因此，该地区有望在预测期内保持其主导地位。 全球mRNA合成原料市场以亚太地区为主，由于研发成本上升、传染病流行和尖端技术的快速引进，预计该地区增长最快。

本研究的目的是阐明近年来各个细分市场和国家/地区的市场规模，并预测未来几年的市场规模。 该报告旨在捕捉被调查国家行业的定性和定量方面的情况。

它还提供了关键方面的详细信息，例如决定市场未来增长的驱动因素和挑战。 此外，它还包含供利益相关者投资的潜在微观市场机会，以及对主要参与者的竞争格局和产品供应的深入分析。

内容

第 1 章执行摘要

  • 市场概况
  • 2019-2029 年全球和细分市场估计和预测
    • 2019-2029 年按地区划分的 mRNA 合成原材料市场
    • mRNA 合成原材料市场，按类型划分，2019-2029 年
    • mRNA 合成原材料市场，按应用分类，2019-2029 年
    • mRNA 合成原材料市场，按最终用户分类，2019-2029 年
  • 主要趋势
  • 调查方法
  • 调查先决条件

第2章全球mRNA合成原料市场的定义和范围

  • 调查目的
  • 市场定义和范围
    • 调查范围
    • 工业发展
  • 本次调查涵盖的年份
  • 货币兑换率

第3章全球mRNA合成原料市场动态

  • mRNA合成原料市场影响分析（2019-2029）
    • 市场驱动力
      • 癌症和慢性病的发病率增加
      • 主要製药公司的积极参与
    • 市场挑战
      • mRNA 合成原料成本高
    • 市场机会
      • COVID-19 造成的必然性
      • mRNA的优势很大

第四章全球mRNA合成材料市场行业分析

  • 波特 5 力模型
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争公司之间的敌对关係
  • 波特 5 力模型的未来方法 (2019-2029)
  • 害虫分析
    • 政治
    • 经济的
    • 社交
    • 技术
  • 投资招聘模式
  • 分析师的建议和结论
  • 主要投资机会
  • 关键成功策略

第 5 章风险评估：COVID-19 的影响

  • 评估 COVID-19 对行业的总体影响
  • COVID-19 之前和 COVID-19 之后的市场情景

第 6 章 mRNA 合成原材料的全球市场：按类型分类

  • 市场概况
  • 全球 mRNA 合成原材料市场：按类型、性能和潜力分析
  • 2019-2029 年全球 mRNA 合成原材料市场类型的估计和预测
  • mRNA 合成原料市场，细分市场分析
    • 封盖剂
    • 核甘酸
    • 质粒DNA
    • 其他

第 7 章 mRNA 合成原材料的全球市场：按应用分类

  • 市场概况
  • mRNA 合成原材料的全球市场：按应用和性能进行的潜力分析
  • 2019-2029年版全球mRNA合成原料市场预估及预测（分应用）
  • mRNA 合成原料市场，细分市场分析
    • 治疗药物的生产
    • 疫苗製造
    • 其他

第 8 章 mRNA 合成原材料的全球市场：按最终用户分类

  • 市场概况
  • mRNA 合成原材料的全球市场：最终用户的性能潜力分析
  • 2019-2029 年最终用户合成 mRNA 原材料的全球市场估计和预测
  • mRNA 合成原料市场，细分市场分析
    • 生物製药和製药公司
    • 首席风险官/首席营销官
    • 学术和研究机构

第 9 章全球 mRNA 合成原材料市场：区域分析

  • mRNA 合成原材料市场，按地区划分的市场概况
  • 北美
    • 美国
      • 按类型估算和预测，2019-2029 年
      • 按应用分类的估计和预测，2019-2029 年
      • 2019-2029 年最终用户的估计和预测
    • 加拿大
  • 欧洲 mRNA 合成原料市场概况
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 其他欧洲
  • 亚太地区 mRNA 合成原料市场概况
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 韩国
    • 其他亚太地区
  • 拉丁美洲 mRNA 合成原料市场概况
    • 巴西
    • 墨西哥
  • 世界其他地区

第 10 章衝突信息

  • 主要市场策略
  • 公司简介
    • 辉瑞公司
      • 关键信息
      • 概览
      • 财务（仅当数据可用时）
      • 类型概述
      • 近期趋势
    • Moderna, Inc.
    • BioNTech SE
    • Bayer AG
    • GlaxoSmithKline
    • Boehringer Ingelheim
    • CureVac
    • Sarepta Therapeutics
    • Alnylam Pharmaceuticals
    • Ionis Pharmaceuticals

第 11 章研究过程

  • 研究过程
    • 数据挖掘
    • 分析
    • 市场评估
    • 验证
    • 出版
  • 调查的特点
  • 调查先决条件

Global mRNA synthesis raw material market is valued at approximately USD2746 million in 2021and and is anticipated to expand at a compound annual growth rate (CAGR) of 2.1% over the forecast period 2022-2029.Using a template consisting of the DNA nucleotide sequence, mRNA is created by the transcription process in the nucleus.mRNA's adaptability and flexibility make it an excellent platform for developing therapeutic or preventive vaccines for a range of chronic and infectious diseases.The growing incidence of cancer and chronic disorders has raised the demand for gene treatments.

The market for mRNA synthesis and manufacturing services is expected to increase significantly over the next few years as a result of the rising demand for gene therapies, and the rise in chronic and infectious diseases. Funding is being provided for the creation of new mRNA therapies to numerous market participants and research institutions. For instance, the Canadian government provided USD 11.1 million in financing to the University of Columbia in October 2022 to further the development of mRNA vaccines. During the current Covid-2019 pandemic, many companies have chosen mRNA vaccine technology to combat coronavirus. Similarly, in December 2022, ExPLoRNA Therapeutics received USD 813,578 in funding from the Bill & Melinda Gates Foundation to further develop its mRNA technology. The emerging involvement of several market players is expected to drive the market further. The development of mRNA synthesis raw materials is hampered by a lack of adaptive, durable, and reasonably priced manufacturing procedures. The high cost of raw resources is the main impediment to progress.

The key regions considered for the Global mRNA synthesis raw material market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market for raw materials used in mRNA synthesis. The United States is forecasted to keep up its position as the industry leader because ofthe existence of sizable mRNA vaccine production facilities by renowned companies such asPfizer and Moderna. Due to this, this region will maintain its dominance throughout the forecast period. A significant percentage of the global market for mRNA synthesis raw materials was owned by Asia Pacific, which is anticipated to be the fastest-growing region due to rising R&D expenditures, a growth in the prevalence of infectious diseases, and a quick uptake of cutting-edge technology.

Major market players included in this report are:

  • Pfizer Inc.
  • Moderna, Inc.
  • BioNTech SE
  • Bayer AG
  • GlaxoSmithKline
  • Boehringer Ingelheim
  • CureVac
  • Sarepta Therapeutics
  • Alnylam Pharmaceuticals
  • Ionis Pharmaceuticals

Recent Developments in the Market:

  • In November 2022, The BASE and Sartorius formed an alliance to facilitate the sharing of development methodologies and strategies for various nucleic acid-based products. The collaboration will enable the efficient application of cutting-edge methods and analytical thinking to design and plan techniques for nucleic acid products.
  • Thermo Fisher Scientific unveiled a customised Dynabeads solution in October 2022, claiming that it aids in the synthesis and purification of mRNA for use in developing and manufacturing vaccines.
  • A final deal was signed by Sanofi in August 2021 to buy all of the outstanding shares of Translate Bio, a company that develops therapies for messenger RNA (mRNA). The purchase is a component of Sanofi's goal to hasten the application of mRNA technology in the creation of pharmaceuticals and vaccines.

Global mRNA synthesis raw material marketReport Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Type, application, end-user, region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporatespotential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Type:

  • Capping Agents
  • Nucleotides
  • Plasmid DNA
  • Others

By Application:

  • Therapeutics Production
  • Vaccine Production
  • Others

By End-user:

  • Biopharmaceutical & Pharmaceutical Companies CROs & CMOs
  • Academic & Research Institutions

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
    • 1.2.1. mRNA Synthesis Raw Material Market, by Region, 2019-2029 (USD Million)
    • 1.2.2. mRNA Synthesis Raw Material Market, by Type,2019-2029 (USD Million)
    • 1.2.3. mRNA synthesis raw material Market, by Application, 2019-2029 (USD Million)
    • 1.2.4. mRNA synthesis raw material Market, by End-user, 2019-2029 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global mRNA Synthesis Raw Material Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global mRNA Synthesis Raw Material Market Dynamics

  • 3.1. mRNA Synthesis Raw Material Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing incidence of cancer and chronic disorders
      • 3.1.1.2. Active Involvement of big pharma players
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of mRNA Synthesis Raw Material
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Necessity created by COVID-19
      • 3.1.3.2. Considerable benefits of mRNA

Chapter 4. Global mRNA Synthesis Raw Material Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global mRNA Synthesis Raw Material Market, by Type

  • 6.1. Market Snapshot
  • 6.2. Global mRNA Synthesis Raw Material Market by Type, Performance - Potential Analysis
  • 6.3. Global mRNA Synthesis Raw Material Market Estimates & Forecasts by Type 2019-2029 (USD Million)
  • 6.4. mRNA Synthesis Raw Material Market, Sub Segment Analysis
    • 6.4.1. Capping Agents
    • 6.4.2. Nucleotides
    • 6.4.3. Plasmid DNA
    • 6.4.4. Others

Chapter 7. Global mRNA synthesis raw material Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global mRNA synthesis raw material Market by Application, Performance - Potential Analysis
  • 7.3. Global mRNA synthesis raw material Market Estimates & Forecasts by Application2019-2029 (USD Million)
  • 7.4. mRNA synthesis raw material Market, Sub Segment Analysis
    • 7.4.1. Therapeutics Production
    • 7.4.2. Vaccine Production
    • 7.4.3. Others

Chapter 8. Global mRNA synthesis raw material Market, by End-user

  • 8.1. Market Snapshot
  • 8.2. Global mRNA Synthesis Raw Material Market by End-user, Performance - Potential Analysis
  • 8.3. Global mRNA synthesis raw material Market Estimates & Forecasts by End-user 2019-2029 (USD Million)
  • 8.4. mRNA synthesis raw material Market, Sub Segment Analysis
    • 8.4.1. Biopharmaceutical & Pharmaceutical Companies
    • 8.4.2. CROs & CMOs
    • 8.4.3. Academic & Research Institution

Chapter 9. Global mRNA Synthesis Raw Material Market, Regional Analysis

  • 9.1. mRNA Synthesis Raw Material Market, Regional Market Snapshot
  • 9.2. North America mRNA Synthesis Raw Material Market
    • 9.2.1. U.S.mRNA Synthesis Raw Material Market
      • 9.2.1.1. Type breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Application breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. End-user breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada mRNA Synthesis Raw Material Market
  • 9.3. Europe mRNA Synthesis Raw Material Market Snapshot
    • 9.3.1. U.K. mRNA Synthesis Raw Material Market
    • 9.3.2. Germany mRNA Synthesis Raw Material Market
    • 9.3.3. France mRNA Synthesis Raw Material Market
    • 9.3.4. Spain mRNA Synthesis Raw Material Market
    • 9.3.5. Italy mRNA Synthesis Raw Material Market
    • 9.3.6. Rest of Europe mRNA Synthesis Raw Material Market
  • 9.4. Asia-Pacific mRNA Synthesis Raw Material Market Snapshot
    • 9.4.1. China mRNA Synthesis Raw Material Market
    • 9.4.2. India mRNA Synthesis Raw Material Market
    • 9.4.3. Japan mRNA Synthesis Raw Material Market
    • 9.4.4. Australia mRNA Synthesis Raw Material Market
    • 9.4.5. South Korea mRNA Synthesis Raw Material Market
    • 9.4.6. Rest of Asia Pacific mRNA Synthesis Raw Material Market
  • 9.5. Latin America mRNA Synthesis Raw Material Market Snapshot
    • 9.5.1. Brazil mRNA Synthesis Raw Material Market
    • 9.5.2. Mexico mRNA Synthesis Raw Material Market
  • 9.6. Rest of The World mRNA Synthesis Raw Material Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Pfizer Inc.
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Type Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Moderna, Inc.
    • 10.2.3. BioNTech SE
    • 10.2.4. Bayer AG
    • 10.2.5. GlaxoSmithKline
    • 10.2.6. Boehringer Ingelheim
    • 10.2.7. CureVac
    • 10.2.8. Sarepta Therapeutics
    • 10.2.9. Alnylam Pharmaceuticals
    • 10.2.10. Ionis Pharmaceuticals

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global mRNA Synthesis Raw Material Market, report scope
  • TABLE 2. Global mRNA Synthesis Raw Material Market estimates & forecasts by Region 2019-2029 (USD Million)
  • TABLE 3. Global mRNA Synthesis Raw Material Market estimates & forecasts byType2019-2029 (USD Million)
  • TABLE 4. Global mRNA synthesis raw material Market estimates & forecasts by Application2019-2029 (USD Million)
  • TABLE 5. Global mRNA synthesis raw material Market estimates & forecasts by End-user2019-2029 (USD Million)
  • TABLE 6. Global mRNA Synthesis Raw Material Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 7. Global mRNA Synthesis Raw Material Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 8. Global mRNA Synthesis Raw Material Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 9. Global mRNA Synthesis Raw Material Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 10. Global mRNA Synthesis Raw Material Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 11. Global mRNA Synthesis Raw Material Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 12. Global mRNA Synthesis Raw Material Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 13. Global mRNA Synthesis Raw Material Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 14. Global mRNA Synthesis Raw Material Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 15. Global mRNA Synthesis Raw Material Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 16. U.S. mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 17. U.S. mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 18. U.S. mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 19. Canada mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 20. Canada mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 21. Canada mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 22. UK mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 23. UK mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 24. UK mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 25. Germany mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 26. Germany mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 27. Germany mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 28. France mRNA synthesis raw material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 29. France mRNA synthesis raw material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 30. France mRNA synthesis raw material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 31. Italy mRNA synthesis raw material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 32. Italy mRNA synthesis raw material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 33. Italy mRNA synthesis raw material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 34. Spain mRNA synthesis raw material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 35. Spain mRNA synthesis raw material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 36. Spain mRNA synthesis raw material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 37. RoE mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 38. RoE mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 39. RoE mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 40. China mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 41. China mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 42. China mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 43. India mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 44. India mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 45. India mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 46. Japan mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 47. Japan mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 48. Japan mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 49. South Korea mRNA synthesis raw material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 50. South Korea mRNA synthesis raw material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 51. South Korea mRNA synthesis raw material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 52. Australia mRNA synthesis raw material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 53. Australia mRNA synthesis raw material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 54. Australia mRNA synthesis raw material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 55. RoAPAC mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 56. RoAPAC mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 57. RoAPAC mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 58. Brazil mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 59. Brazil mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 60. Brazil mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 61. Mexico mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 62. Mexico mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 63. Mexico mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 64. RoLA mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 65. RoLA mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 66. RoLA mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 67. Row mRNA Synthesis Raw Material Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 68. Row mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 69. Row mRNA Synthesis Raw Material Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 70. List of secondary sources, used in the study of global mRNA Synthesis Raw Material Market
  • TABLE 71. List of primary sources, used in the study of global mRNA Synthesis Raw Material Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global mRNA Synthesis Raw Material Market, research methodology
  • FIG 2. Global mRNA Synthesis Raw Material Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global mRNA Synthesis Raw Material Market, key trends 2021
  • FIG 5. Global mRNA Synthesis Raw Material Market, growth prospects 2022-2029
  • FIG 6. Global mRNA Synthesis Raw Material Market, porters 5 force model
  • FIG 7. Global mRNA Synthesis Raw Material Market, pest analysis
  • FIG 8. Global mRNA Synthesis Raw Material Market, value chain analysis
  • FIG 9. Global mRNA Synthesis Raw Material Market by segment, 2019 & 2029 (USD Million)
  • FIG 10. Global mRNA Synthesis Raw Material Market by segment, 2019 & 2029 (USD Million)
  • FIG 11. Global mRNA Synthesis Raw Material Market by segment, 2019 & 2029 (USD Million)
  • FIG 12. Global mRNA Synthesis Raw Material Market by segment, 2019 & 2029 (USD Million)
  • FIG 13. Global mRNA Synthesis Raw Material Market by segment, 2019 & 2029 (USD Million)
  • FIG 14. Global mRNA Synthesis Raw Material Market, regional snapshot 2019 & 2029
  • FIG 15. North America mRNA Synthesis Raw Material Market2019 & 2029 (USD Million)
  • FIG 16. Europe mRNA Synthesis Raw Material Market2019 & 2029 (USD Million)
  • FIG 17. Asia pacific mRNA Synthesis Raw Material Market2019 & 2029 (USD Million)
  • FIG 18. Latin America mRNA Synthesis Raw Material Market2019 & 2029 (USD Million)
  • FIG 19. Global mRNA Synthesis Raw Material Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable